Atossa Therapeutics Inc reports results for the quarter ended in December - Earnings Summary

Atossa Therapeutics

22/03/2023 20:38

* Atossa Therapeutics Inc  ATOS.OQ  reported a quarterly
adjusted
loss of 6 cents​​ per share for the quarter ended in December.
The lone analyst forecast for the quarter was for a loss of 6
cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Atossa Therapeutics Inc's reported EPS for the quarter was
a
loss of 6 cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Atossa Therapeutics Inc shares had risen by 26.3% this
quarter.
    * The company reported a quarterly loss of $7.49 million.
    * Wall Street's median 12-month price target for Atossa
Therapeutics Inc is $5.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
March 22 at 08:38 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      -0.06          -0.06          Met
 Sep. 30 2022      -0.06          -0.06          Met
 Jun. 30 2022      -0.06          -0.05          Beat
 Mar. 31 2022      -0.05          -0.04          Beat